Lutetium(177 lu)oxodotreotide

Lutathera Solution for Infusion 370 MBQ/ML

370 Mbq/ml injection, solution (radiopharmaceutical)SingaporeAuthorisedAuthorised 1 Jun 2020

In other countries

The same active substances on other registers, the same brand first.

LutatheraCanada · 370 MBq / ML · Solution · Novartis Pharmaceuticals Canada INCSame brand
LutatheraEuropean Union · Advanced Accelerator ApplicationsSame brand
LutatheraCroatiaSame brand
LutatheraItaly · Soluzione per infusione · Novartis Europharm LimitedSame brand
Lutathera 370 MBq/ml, oplossing voor infusieNetherlands · Oplossing voor infusie · Novartis Europharm LimitedSame brand
EndolucinBeta 40 GBq/mL, radiofarmaceutische precursor, oplossingNetherlands · Radiofarmaceutische uitgangsstof · ITM Medical Isotopes GmbHSame substance
Ilumira 37 GBq/ml radiofarmaceutische uitgangsstof, oplossing

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lutetium(177 lu)oxodotreotide

Lutathera Solution for Infusion 370 MBQ/ML

370 Mbq/ml injection, solution (radiopharmaceutical)SingaporeAuthorisedAuthorised 1 Jun 2020

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Netherlands · Radiofarmaceutische uitgangsstof · Shine Europe B.V.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lutetium(177 lu)oxodotreotide
Strength: 370 Mbq/ml
Dosage form: injection, solution (radiopharmaceutical)
Route: intravenous
Register: Singapore (HSA)
Status: Authorised
Status in the register: Registered
Authorised: 1 Jun 2020
Registration: SIN15947P
Marketing authorisation holder: Novartis (Singapore) Pte LTD
Manufacturer: Advanced Accelerator Applications (Italy) s.r.l. / Advanced Accelerator Applications Ibérica S.L.U., SPAIN / ITALY
ATC code: V10XX04
Group: Various
Supply: Prescription Only